Dobutamine stress echocardiography in patients undergoing liver transplantation evaluation.

Department of Internal Medicine, University of Florida College of Medicine, Gainesville 32610-0277, USA.
Transplantation (Impact Factor: 3.78). 06/2000; 69(11):2354-6. DOI: 10.1097/00007890-200006150-00023
Source: PubMed

ABSTRACT Coronary artery disease has an important impact on perioperative morbidity and mortality in patients undergoing liver transplantation. To assess the role of dobutamine stress echocardiography (DSE) in these patients, DSE was included in the preoperative evaluation.
Patients under consideration for liver transplantation underwent detailed clinical history, electrocardiography, and echocardiography. Patients with documented coronary disease or symptoms of myocardial ischemia underwent angiography. The remaining patients with cardiac risk factors, atypical chest pain, or age > or = 60 years underwent DSE.
These 121 patients (77 men and 44 women) ranged in age from 34 to 73 years (mean 53). Among the 61 patients who underwent liver transplantation, DSE was normal in 25, nondiagnostic in 34 because of inadequate heart rate response, and abnormal in two patients. Major perioperative events occurred in eight patients, all with normal or nondiagnostic DSE studies (negative predictive value 86%).
In patients with low to moderate risk of cardiac disease, DSE performed as part of an evaluation for liver transplantation is a poor predictor of major perioperative events.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Cardiac risk assessment prior to kidney and liver transplantation is controversial. Given the paucity of available organs, selecting appropriate recipients with favorable short and long term cardiovascular risk profile is crucial. Using noninvasive cardiac imaging tools to guide cardiovascular risk assessment and management can also be challenging and controversial. In this article, we address the burden of coronary artery disease among kidney and liver transplant candidates and review the literature pertaining to the diagnostic accuracy and the prognostic value of noninvasive cardiac imaging techniques in this population.
    Journal of Nuclear Cardiology 12/2014; 21(6). · 2.65 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: End stage liver disease (ESLD) is associated with many specific derangements in cardiovascular physiology, which influence perioperative outcomes and may profoundly influence diagnostic and management strategies in the preoperative period. This review focuses on evidence-based diagnosis and management of coronary, hemodynamic and pulmonary vascular disease in this population with an emphasis on specific strategies that may provide a bridge to transplantation. Specifically, we address the underlying prevalence of cardiovascular disease states in the ESLD population, and relevant diagnostic criteria thereof. We highlight traditional and non-traditional predictors of cardiovascular outcomes following liver transplant, as well as data to guide risk-factor based diagnostic strategies. We go on to discuss the alterations in cardiovascular physiology which influence positive- and negative-predictive values of standard noninvasive testing modalities in the ESLD population, and review the data regarding the safety and efficacy of invasive testing in the face of ESLD and its co-morbidities. Finally, based upon the totality of available data, we outline an evidence-based approach for the management of ischemia, heart failure and pulmonary vascular disease in this population. It is our hope that such evidence-driven strategies can be employed to more safely bridge appropriate candidates to liver transplant, and to improve their cardiovascular health and outcomes in the peri-operative period.
    World journal of gastroenterology : WJG. 08/2014; 20(31):10651-10657.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The feasibility, safety, and value of coronary computed tomographic angiography (CCTA) in evaluating orthotopic liver transplant (OLT) candidates is unknown. We studied a cohort of consecutive OLT candidates with intermediate to high risk of coronary artery disease (CAD). Intermediate risk candidates received CCTA, and those at high risk or with abnormal noninvasive testing underwent invasive coronary angiography (ICA). One-hundred consecutive patients were evaluated. Fifty subjects underwent a CCTA, 71.4% were beta-blocked, the image quality was “good” or “excellent” in 71.4% of cases, and there was no event of significant contrast-induced nephropathy. Twenty (20%) subjects were found to have severe CAD (≥70% stenosis) by CCTA and/or ICA. Independent predictors of severe CAD were age (OR=5.4 per 10-year increment, 95%CI=1.7-17.0; P=0.004), dyslipidemia (OR=12.3, 95%CI=2.6-57.6; P=0.001) and chest pain (OR=6.0, 95%CI=1.2-29.1; P=0.03). Implementing CCTA in the evaluation of intermediate/high CAD risk OLT candidates is challenging but feasible and seems safe.
    Angiology 12/2014; · 2.37 Impact Factor


Available from